| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1276880B1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | EP1056452B1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 07/19/2006 | EP0898580B1 Methods and means for inhibition of cdk4 activity |
| 07/19/2006 | CN1805960A 7-azaindoles and use thereof as therapeutic agents. |
| 07/19/2006 | CN1805948A Stabilized derivatives of ascorbic acid. |
| 07/19/2006 | CN1805936A VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones |
| 07/19/2006 | CN1805934A 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor |
| 07/19/2006 | CN1805933A 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs) |
| 07/19/2006 | CN1805930A Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 07/19/2006 | CN1805760A Thorium-227 for use in radiotherapy of soft tissue disease |
| 07/19/2006 | CN1805758A Nucleotide and cellular vaccine composition |
| 07/19/2006 | CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors |
| 07/19/2006 | CN1805742A Cis-imidazolines as MDM2 inhibitors |
| 07/19/2006 | CN1804038A VEGF expression-inhibiting siRNA and application thereof |
| 07/19/2006 | CN1804037A Expression method of glucosal related protein and application thereof |
| 07/19/2006 | CN1803834A Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation |
| 07/19/2006 | CN1803832A 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 07/19/2006 | CN1803823A SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application |
| 07/19/2006 | CN1803813A Novel synthesis process of anti-cancer Sunpla |
| 07/19/2006 | CN1803806A Preparation of ekb-569 and related intermediates |
| 07/19/2006 | CN1803799A Camptothecin derivative used as anti-tumor agent and preparation method thereof |
| 07/19/2006 | CN1803788A Polymethoxylated flavone derivative with anticancer activity, its pharmaceutical composition, preparation method and application |
| 07/19/2006 | CN1803786A Red sage root water soluble ingredient derivative ERJT-12 and its application in cancer resistance |
| 07/19/2006 | CN1803186A Chinese medicine for treating hysteromyoma |
| 07/19/2006 | CN1803173A Medicine for treating digestive tract tumor and its preparation method |
| 07/19/2006 | CN1803169A Medicinal composition for treating leukaemia |
| 07/19/2006 | CN1803153A Toad essence capsule and its preparation method |
| 07/19/2006 | CN1803137A Process for producing crystal |
| 07/19/2006 | CN1803134A Preparation method of magnetic nanometer granule containing mitocin-C |
| 07/19/2006 | CN1803133A Magnetic nanometer granule containing mitocin-C and its uses |
| 07/19/2006 | CN1803131A Anticancer diterpene analog compound intravenous injection formulation, and its preparation method and uses |
| 07/19/2006 | CN1803032A Pure gingko liquor preparation method |
| 07/19/2006 | CN1803005A Highly water-soluble horse radish oil powder preparation method |
| 07/19/2006 | CN1264862C Diphtherin-gonadoliberin chimeric protein |
| 07/19/2006 | CN1264861C Receptor targeting chimeric toxin with junctional sequence |
| 07/19/2006 | CN1264859C Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264844C 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 07/19/2006 | CN1264841C Preparation of anti-cancer active material in camptothecinum cell and method for restraining cancer cell |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264829C 1,3-di[N-(2-methoxy) phenyl] piperazine]-1- acetone hydrochloride and its preparation method and application |
| 07/19/2006 | CN1264824C Quinazoline derivatives |
| 07/19/2006 | CN1264817C Certain cyclic thio substituted acylaminoacid amide derivatives |
| 07/19/2006 | CN1264541C Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and food compositions containing said extract |
| 07/19/2006 | CN1264530C Freeze-dried 'Shenqifuzheng' powder injection preparing process |
| 07/19/2006 | CN1264529C Freeze-dried 'Shenqifuzheng' powder for injection preparing process |
| 07/19/2006 | CN1264527C Novel olive kernel leaf extracts and preparation process and medical use thereof |
| 07/19/2006 | CN1264521C Nano selenium of chitin and its preparation method |
| 07/19/2006 | CN1264507C Application of skullcap root extract in preparing medicine for nasopharyngeal carcinoma |
| 07/19/2006 | CN1264501C Process for preparing white arsenic nano particles |
| 07/18/2006 | US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078525 Antiproliferative agents; anticancer agents; antiinflammatroy agents; Alzheimer's disease; viricides; fungicides |
| 07/18/2006 | US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078433 FC101 and analogs as a method of treatment for cancer |
| 07/18/2006 | US7078427 Bioavailability; anticancer agents; viricides |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 07/18/2006 | US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078389 Hybridization of a mutagen substituted single-strand nucleic acid molecule with DNA causes a mutation at a specific site; antiproliferative and anticarcinogenic agents; gene therapy |
| 07/18/2006 | US7078376 blood disorders; analgesics; nausea; cardiovascular disorders; anticancer agents; hypotensive agents; headaches; edema; diarrhea; thrombosis; reducing dosage |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078063 Water soluble extract from plant of Solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/18/2006 | US7078028 Anti-neoplastic viral agents |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/18/2006 | CA2216592C Benzothiophene compounds, intermediates, compositions, and methods |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/13/2006 | WO2006074451A2 Targeted chimeric molecules for cancer therapy |
| 07/13/2006 | WO2006074262A1 Ubiquitin ligase inhibitors |
| 07/13/2006 | WO2006074071A1 Framework residue substituted humanized col-1 antibodies and their use |
| 07/13/2006 | WO2006073748A2 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | WO2006073443A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 07/13/2006 | WO2006073202A1 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072831A1 Pyrrolopyrazoles, potent kinase inhibitors |
| 07/13/2006 | WO2006072783A1 Sulfasalazine analogues as nf-kb inhibitors |
| 07/13/2006 | WO2006072626A1 Kir-binding agents and methods of use thereof |